How Innate Pharma (ENXTPA:IPH) Story Is Shifting Around 2026 Catalysts And €8 Target [Yahoo! Finance]
Innate Pharma S.A. - American Depositary Shares (IPHA)
Company Research
Source: Yahoo! Finance
Analysts are now discussing an updated €8 price target for Innate Pharma, while the fair value estimate sits at €6.10 with no change to the underlying model. This shift is being framed around what both bullish and bearish voices see in the 2026 catalyst cluster, including funding needs and how upcoming oncology readouts could influence sentiment. As you read on, you will see how these moving pieces fit together and what to watch as the story develops. Stay updated as the Fair Value for Innate Pharma shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Innate Pharma. What Wall Street Has Been Saying ?? Bullish Takeaways BTIG assumed coverage of Innate Pharma with a Buy rating and an $8 price target, framing 2026 as a "crucial catalyst stretch" that could reshape how the pipeline is valued. BTIG highlights three oncology assets with key 2026 events, including monalizumab PACIFIC-9 topline data and IPH4502 Ph
Show less
Read more
Impact Snapshot
Event Time:
IPHA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPHA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPHA alerts
High impacting Innate Pharma S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IPHA
News
- Innate Pharma to Participate in the Kempen Life Sciences ConferenceBusiness Wire
- Innate Pharma Files Its 2025 Universal Registration Document (Document D'enregistrement Universel) and 2025 Form 20-f Annual Report [Yahoo! Finance]Yahoo! Finance
- Innate Pharma Files Its 2025 Universal Registration Document (Document D’enregistrement Universel) and 2025 Form 20-f Annual ReportBusiness Wire
- Innate Pharma S.A. (IPHA) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Innate Pharma GAAP EPS of -€0.55, revenue of €9.01M [Seeking Alpha]Seeking Alpha